Summit Wealth & Retirement Planning’s Medifast MED Stock Holding History
Bought
Maintained
Sold
Other funds holding MED
RHJA
Summit Wealth & Retirement Planning's MED Position: Q3 2022 in Review
Summit Wealth & Retirement Planning sold out of Medifast (MED) in Q3 2022, closing a stake of 2,238 shares — an estimated $404K sold.
Summit Wealth & Retirement Planning first reported a position in MED in Q4 2020 and held it in 7 quarters. The position peaked at $864K in Q4 2020. 263 funds tracked by Wall St. Rank hold MED as of Q3 2022.
- Summit Wealth & Retirement Planning reported no remaining Medifast position as of Q3 2022 after selling out during the quarter.
- Summit Wealth & Retirement Planning sold 2,238 Medifast shares in Q3 2022, an estimated $404K.
- Summit Wealth & Retirement Planning first reported a position in Medifast in Q4 2020 and held it in 7 quarters.
- Summit Wealth & Retirement Planning's Medifast position peaked at $864K in Q4 2020.
- 263 funds tracked by Wall St. Rank held Medifast as of Q3 2022.
Based on Summit Wealth & Retirement Planning's 13F filing for Q3 2022, filed 14 Nov 2022.